Gene-editing pipeline takes off

被引：27

作者：

Mullard, Asher

机构：

来源：

NATURE REVIEWS DRUG DISCOVERY | 2020年 / 19卷 / 06期

关键词：

D O I：

10.1038/d41573-020-00096-y

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Clinical trials of genome-editing agents - including CRISPR-Cas9 editors, zinc finger nucleases and TALENs - are pushing ex vivo, immuno-oncology and in vivo treatment frontiers.

引用

页码：367 / 372

页数：6

共 50 条

[1] Exoplanet find, oil pipeline and a gene-editing first
不详
Nature, 2017, 551 (7681) : 418 - 419
[2] How DNA fends off a favourite gene-editing tool
Nature, 2018, 561 : 289 - 289
[3] The Gene-Editing Conversation
Nisbet, Matthew
AMERICAN SCIENTIST, 2018, 106 (01) : 15 - 19
[4] How DNA fends off a favourite gene-editing tool
不详
NATURE, 2018, 561 (7723) : 289 - 289
[5] Gene-Editing Policy
Worley, Dale R.
AMERICAN SCIENTIST, 2018, 106 (03) : 131 - 132
[6] Gene-editing nucleases
Monya Baker
Nature Methods, 2012, 9 : 23 - 26
[7] Gene-editing nucleases
Baker, Monya
NATURE METHODS, 2012, 9 (01) : 23 - 26
[8] The first gene-editing treatment
Regalado, Antonio
MIT TECHNOLOGY REVIEW, 2024, 127 (01): : 24 - 24
[9] The Public and the Gene-Editing Revolution
Blendon, Robert J.
Gorski, Mary T.
Benson, John M.
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (15): : 1406 - 1411
[10] Erratum: Gene-editing nucleases
Monya Baker
Nature Methods, 2012, 9 (4) : 418 - 418

← 1 2 3 4 5 →